Every 5 minutes someone in America dies of an overdose. The single greatest barrier to increasing naloxone access is FDA’s designation of naloxone as prescription-only. For the first time, we highlight how prescription-only status cascades into myriad legal and practical barriers in ways that are unexpected. We ask FDA to remove generic naloxone’s prescription requirement for Harm Reduction programs, so that we may prevent overdose deaths more effectively. Remedy Alliance (For The People) operates the Opioid Safety and Naloxone Network (OSNN) Buyers Club, established in 2012. The Buyers Club is a collective of over 100 harm reduction programs who distribute naloxone directly to people who use drugs, their loved ones and community.
